Calendar of Events

We often hear the phrase “funded investigators are made, not born,” but is there just one mold for a “made” funded investigator in the world of toxicology, which relies on external funding to “get the job done”? The field of toxicology is much broader than the mechanisms by which exogenous agents induce human disease and although this area of toxicology represents a major area of funding for many toxicological researchers, other sources are available! Our first speaker is Dr. Deborah Keil from Montana State University. Dr. Keil will talk about funding that she has received from the Bureau of Land Management as well as from organizations that support Native American health. Dr. Laxmikant Deshpande of Virginia Commonwealth University has had success with funding from the Department of Defense through the Congressionally Directed Medical Research Programs (CDMRP). Dr. Kendall Wallace is from the University of Minnesota Medical School and is a Past President of SOT. Dr. Wallace has had success both with traditional funding mechanisms (i.e., National Institutes of Health) as well as with funding from corporate entities. Each of these researchers explore complex toxicological problems and have built their own molds for the funding that works best for their research interests, and they will share their stories of successes, failures, and lessons learned.

Join the International Pediatric Dermatology Congress and gain insights on recent updates as well as be one of the contributors in the advancement of this field.
Prices: USD 199 to 2199

Global Summit on Toxicology and Pharmacology is designed to bring forth the most up to date information with a complete approach to diverse areas of interest. The topics of the summit will reflect the current advances, current trends, future trends and novel approaches in Toxicology and Pharmacology

Please join us with your peers from around the world for this wonderful opportunity to reach the largest assembly of participants from the Toxicology and Pharmacology community, meet with thought leadership experts, share your new research, and show off your cutting-edge expertise at this event.

ABSTRACT SUBMISSION: https://www.ologymavens.com/cme/pharmacology/toxicology-conferences/abstract-submission

REGISTRATION: https://www.ologymavens.com/cme/pharmacology/toxicology-conferences/registration

E: toxicologycongress@ologymavensmeetings.com

This webinar features the SOT Learning Framework for undergraduate toxicology education. The framework project lead Joshua Gray, US Coast Guard Academy, and Chris Curran, Northern Kentucky University and chair of FUTURE, the newly launched SOT Faculty United for Toxicology Undergraduate Recruitment and Education Committee, will provide an overview of this resource and explain how toxicology lab and lecture courses can be (re)designed to incorporate key concepts and align with the NSF/AAAS Vision and Change framework for undergraduate biology education. Educators will have the opportunity to share their own ideas and to ask questions related to their course development and instruction.

This Framework is designed around five Core Concepts: Evolution; Biological Information; Risk and Risk Management; Systems Toxicology; and Pathways and Transformations for Energy and Matter. Underlying Toxicology Concepts and Learning Objectives are used to emphasize particular aspects of toxicology related to the type of course being offered, such as environmental toxicology or pharmacological toxicology. Case studies and example learning objectives are then used to provide specific examples explaining the Toxicology Concepts and Learning Objectives.

Those who are not able to participate in the live session will be able to access the recording and slides on the SOT website along with the previous Undergraduate Educator Network webinars: www.toxicology.org/education/edu/ugWebinars.asp

University Club, University of Pittsburgh
Pittsburgh, PA
May 1-2, 2019

For more details, please visit the AESOT website below.

Incorporating insights from 25+ industry leading speakers, this uniquely specific forum assesses key clinical and translational hurdles and the hottest emerging research necessary to achieve the potential of next-generation CKD drugs.

Registration is required.

8:30 am-12:45 pm ET (UTC-4)

Attend in person at US FDA, College Park, Maryland or by webcast at no charge.

Speakers will explore the science behind new international trends in the in silico safety assessment of chemical exposure. Two common themes shared by international regulatory bodies are the critical issues involved in alternative methods to animal testing and the rigorous treatment of uncertainties to obtain reproducible and transparent weight-of-evidence approaches to decision making. For alternative methods to repeated-dose toxicity, toxicokinetics and metabolism are emphasized to understand chemical exposure and bioavailability. Biokinetics is further being applied to data-waiving methods such as the Threshold of Toxicological Concerns (TTC). Internal TTC is a TTC concept for situations of low internal exposure, where this value is more relevant than the external exposure. Development of internal TTCs requires a significant amount of data and computational tools (e.g., PBPK modeling) to convert the chemical specific external doses (i.e., NOAELs) in the TTC databases into an estimate of the internal exposure. Presenters will review the common concerns related to the relevance of in silico chemical safety assessment that may hinder its adoption if not properly addressed.

Chair: Kirk Arvidson, US FDA, College Park, MD, USA
Co-chair: Chihae Yang, MN AM, Nurnberg, Germany

Presentations include:

8:30 AM – 8:40 AM
Welcome and Overview, TBD

Speaker Introductions
Kirk Arvidson, US FDA, College Park, MD

8:40 AM–9:20 AM
Drivers for the Application and Acceptance of In Silico Safety Assessment Based on Chemical Exposure
Mark Cronin, Liverpool John Moores University, Liverpool, UK

Identifying, Estimating, and Communicating Uncertainty within In Silico Approaches to Chemical Safety Assessment
James F. Rathman, The Ohio State University, Columbus, OH

10:00 AM – 10:20 AM Break

10:20 AM – 11:00 AM
Study on PBPK and Biologically Based Dose-Response Modeling for Safety Assessment Considerations: Utility and Challenges
Annie Lumen, NCTR, Jefferson, AR

11:00 AM – 11:40 AM
Transformation of Threshold of Toxicological Concerns (TTC) to Internal TTC: Why Internal Exposure Matters and How We Will We Get There
Corie Ellison, Procter and Gamble, West Chester, OH

11:45 AM–12:45 PM
Roundtable Discussion
Moderator: Kirk Arvidson, US FDA, College Park, MD
All speakers

Questions concerning the regulatory science are encouraged from the audience on-site and from webcast participants for the roundtable discussion. Regulatory policy will not be discussed.

Website: https://diabetesmeet.conferenceseries.com/

Brochure: https://diabetesmeet.conferenceseries.com/conference-brochure.php

Email: diabetesmeet@diabetesconferences.net

This Conference provides a great opportunity for specialists with interest in intracranial hemorrhage and head injury management.

Abstract Submission Deadline: February 11 2019
Early Bird Registration Deadline: February 28 2019

Please join us at the 20th Pollutant Responses in Marine Organisms (PRIMO 20) meeting, to be held in Charleston SC from May 19 - May 22, 2019.

PRIMO 20 aims to provide an interdisciplinary scientific forum for discussing research on the environmental effects of anthropogenic activities on the health of our oceans and the organisms within. Scientific sessions will focus on the mechanisms of toxicity towards aquatic organisms, with sessions being held on –omic approaches, xenobiotic metabolizing enzymes, signal transduction, pharmaceutical and personal care products, nanoparticles and microplastics, developmental and transgenerational effects, and epigenetics, amongst others.

Abstract submission deadline - February 1, 2019

Student travel award deadline - February 1, 2019

Early bird registration - March 1, 2019

Registration is required.

Registration is required.

Lyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion.
Attend this conference along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science, materials characterisation, novel and alternative technologies, mathematical modelling and regulatory updates.

Venue Details: Holiday Inn London - Kensington Forum, 97 Cromwell Road, London, SW7 4DN, United Kingdom

NEW DATE! On June 3-4, 2019, the National Academies of Sciences, Engineering, and Medicine will hold a workshop on “Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions” in Washington, DC. The workshop’s aim is to explore ways to overcome challenges that present themselves to the US Environmental Protection Agency (US EPA) during evidence integration in chemical assessments, with particular emphasis on the use of mechanistic data.

The event will explore many facets of evidence integration, which is a summary step of the systematic review in human health assessments conducted by the US EPA National Center for Environmental Assessment. Topics to be covered include (1) lessons learned from the evidence integration colloquium held in Lisbon, Portugal, in 2017; (2) best practices in evidence integration; (3) approaches for using mechanistic data to integrate evidence from animal and human studies; (4) case studies of systematic review-enabled evidence integration; and (5) practical approaches to expedited evidence integration.

The workshop organizing committee will review poster abstracts centered on at least one of the aforementioned topics, with an emphasis on the use of mechanistic data, for inclusion in poster presentations featured during the workshop. Interested parties should submit their abstracts for review by March 22, 2019, after which date the organizing committee will review them and select those to be included in the workshop.

To register and for additional details, please visit the

The Machine Learning Boot Camp will be led by a team of biostatisticians from leading institutions, all with expertise in applying machine learning to biomedical research.

This two-day intensive training will provide a broad introduction to machine learning methodology with applications in biomedical research. The Boot Camp will integrate seminar lectures with hands-on R lab sessions to put concepts into practice. Emphasis will be given to supervised (e.g., penalized methods, classification and decision trees, survival forests) and unsupervised methods (e.g., clustering algorithms, principal components) with numerous case studies and biomedical applications. The workshop will conclude with a brief overview on ‘deep learning’ approaches DOs and DON’Ts.

There is a limited capacity for the Boot Camp. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate.

Recommendations:

Each participant should have an introductory background in statistics, familiarity with R/R Studio, and a personal laptop with R/RStudio installed prior to the first day of the workshop, as all lab sessions will be done on your personal laptop. If you have never used R before a brief tutorial/refresher will be provided on the first day of Training. R is available for free download and installation on Mac, PC, and Linux devices. Please review the R Installation Guide on our

The Epigenetics Boot Camp is led by Dr. Andrea Baccarelli and colleagues, a team with over 36 years of experience in epigenetics from Columbia University, Icahn School of Medicine at Mount Sinai, and Harvard University.

This two-day intensive boot camp integrates the principle concepts of epigenetics and the effects of risk factors on the epigenome as we step through the key components of designing and executing DNA methylation studies. The workshop will integrate seminar lectures with hands-on computer sessions to put concepts into practice. Emphasis will be given to leveraging existing resources from ongoing studies and initiating new investigations. The afternoon lab sessions will provide an opportunity to work hands-on with real methylation data generated by the Illumina Infinium MethylationEPIC (850k) BeadChip platform. Participants will learn and practice data handling, cleaning, and basic analysis of epigenome-wide DNA methylation data.

There is a limited capacity for the Boot Camp. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate. Basic familiarity with R is recommended to get the most out of the Boot Camp, with tutorials on our website.

• Paid registration required through RegFox:

Over 60+ presentations, case studies and panel discussions will focus on the key issues in drug discovery and medicinal chemistry.

- Drug Discovery Innovation and Strategies
NEW FOR 2019! Focused Session: Protein Degradation In Drug Discovery and Drug Design

- Biologics and Small Molecule Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology

We have been working with companies including: Endocyte, MTR, Actinium Pharmaceuticals, Tagworks, Bayer and Roche, to assemble this agenda. The key focus of which will be exploring how to advance the therapeutic potential of radiation. The important role of diagnostic imaging is also key to providing a truly well-rounded conference in this field. As such, fully appreciating the potential that combinations of theranostics and diagnostics offer will be integral throughout.

Early booking and group discounts apply, start-up and academic rates are available - see the website for details.

Participants have come from these leading companies: Abbott, Abbott Diabetes Care, AbbVie, Actelion, Johnson And Johnson, Agilent, Aimmune Therapeutics, Align Technology, Amgen, Answers And Insights, AplusA Bell Falla, BioFire Diagnostics, bioMerieux, Branding Science, Cipla BioTec, Clorox, Depomed Inc., Dermira, Eli Lilly and Company, Enlace Sophia S.A. de C.V., Fresenius Kabi, Fulcrum Research Group, Genentech, Gilead Sciences, Inc., Grifols, GSG, Healogix LLC, Health Strategies Group, Human Branding, InCrowd, Intuitive Surgical, Jazz Pharmaceuticals, Kantar Health, Labcyte Inc., Larchmont Ventures, Lifescience Dynamics, M Health, Markelytics, MD Analytics Inc., Medefield America, Medicines360, MedSurvey, Natera, Neurocrine Biosciences, Omeros Corporation, OncoCyte, Pfizer, Inc, Promega, QualWorld, QuintilesIMS, Relypsa, Inc, Research Partnership, Roche, Sanofi Genzyme, Santen, Seattle Genetics, Sedulo Group, Segmedica, Shapiro+Raj, Spectrum 28, Takeda Oncology, The ABIS Group, Theravance, ThinkGen, Toyota Financial Services, Versartis, Whole Biome, Inc., Xcenda, and more!

Over 20 presentations and case studies on the latest discoveries in CNS along with patient stratification and biomarker development for neuroscience.

- Drug Discovery Strategies in CNS
- Translation, Stratification and Precision Medicine In Neuroscience

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Price:
Academic - 2 Day Pass: EUR 630.0

Speakers: Nick Brandon, Chief Scientist-Neuroscience, AstraZeneca, Johan Luthman, Vice President Neuroscience Clinical Development, Eisai, Pradeep Nathan, Vice President CNS Clinical Development and Head of Experimental Medicine, Heptares, Emilio Merlo Pich, Executive Director Neurology and Quantitative Medicine Neuroscience Therapeutic Area, Takeda, Thomas P. Misko, Lead Scientist and Senior Scientific Director, Translational Neuroscience, AbbVie, Janet Nicholson, Director, CNS Diseases Research, Boehringer Ingelheim, Holger Monenschein, Director, Medicinal Chemistry, Neuroscience Drug Discovery Unit, Takeda, Mikhail Kalinichev, Director, In Vivo Neurology, Ipsen, Johannes Krupp, Director, Ipsen, Magnus Ivarsson, Vice President, Head of Discovery, Rodin Therapeutics, Charlie Bailey, Global Head, Neuroscience BDandL, Novartis

Venue Details: Maritim proArte Hotel Berlin, 151 Friedrichstraße, Berlin, 10117, Germany

Time: 7:30 am - 5:00 pm

Tackling critical challenges in the discovery, translation, development and commercialization of biomarker-driven and Dx-enabled therapeutics, this meeting will draw on the transferable learnings from a multitude of disease areas to improve treatment decision making and push the boundaries of the standard of care for patients.

19th - 20th June, 2019

The PI Crash Course will be led by a team of experienced leaders and scientists in the fields of environmental sciences, epigenetics, genomics, epidemiology, immunology, neuroscience and bioinformatics.

This two-day intensive crash course integrates the principle skills that future and new PIs did not develop during their post-doctoral training but will be necessary to survive as a new lab leader and manager. Whether you are a doctoral student, postdoc, new PI, or looking to start your own lab, as a lab leader you will immediately be confronted on daily basis by a variety of situations that you must be prepared to handle. This crash course will provide you the tools you need to start your lab on the right foot.

There is a limited capacity for the Crash Course. Senior post-doctoral students and associate research scientists about to start their independent position search are particularly welcome to attend, and we strongly encourage new and recent PIs to participate as it is never too late to get an overview of the survival skills that you will need throughout your career.

• Paid registration required through RegFox:

Across 3 days of in-depth discussion, share perspectives with industry leaders and overcome translational drug development challenges including: clinical trial design in a hyper-competitive landscape, targeting alternative proinflammatory pathways, and the potential of emerging antigen-specific and bio-therapeutics.

This three-day intensive course will cover some of the recent developments in causal mediation analysis and provide practical tools to implement these techniques and assess the mechanisms and pathways by which causal effects operate. Led by a team of experts in causal mediation techniques at Columbia University, this course will integrate lectures and discussion with hands-on computer lab sessions using R, SAS, SPSS and Stata. The course will cover the relationship between traditional methods for mediation in environmental health, epidemiology, and the social sciences and new methods in causal inference using a wide variety of examples to illustrate the techniques and approaches.

There is a limited capacity for the Boot Camp. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate.

Registraton Deadline, July 3rd 2019

More information:

• Paid registration required through RegFox:

The Radiation Safety Officer Training will be led by Norman Kleiman and colleagues, a team with extensive expertise in radiation from Columbia University’s Center for Radiological Research, Department of Environmental Health Sciences, Department of Medicine, and Department of Environmental Health & Safety.

Columbia University’s Department of Environmental Health Sciences offers a 40-hour course to meet the Nuclear Regulatory Commission (NRC) Class C Radiation Safety Officer (RSO) training requirements. The curricula is designed for individuals working in academia, industry, and government laboratories seeking training in the safe handling of radioisotopes to meet local, state, or federal regulatory and/or training requirements. Participants that complete this course will fulfill the 40-hour requirement as stated in

The NIH Grant Writing Boot Camp be led by Morgan Giddings and Stefanie Robel from Marketing Your Science, LLC, both of whom have extensive experience as researchers and grant writers.

This two-day intensive boot camp is unique in that it dives into what truly matter when applying for grants, without fluff like "how to follow instructions of the funder carefully." Whether you are new to grant writing, “thought you knew what you were doing” but aren’t getting the results you want, or simply want to learn some key elements of being more persuasive in your proposals to become more efficient at writing, this course will teach you the Critical Path to Funding as a vehicle to get you there. Please note that due to the high demand, individual participant proposals or proposal sections will not be reviewed by instructors - however, there will be a few hot seats to illustrate how the theory meets the practical implementation. Additionally, if you have a previously rejected proposal you wish to work on, you are encouraged to bring it along with the reviewer comments.

There is a limited capacity for the Crash Course. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate to form a strong basis for funding early on.

• Paid registration required through RegFox:

The course is intended to benefit individuals from biotechnology and pharmaceutical companies working with either small or large molecules, along with those from CROs, regulatory agencies and academia who are interested in toxicology and its application in safety assessment of drugs and medical products and for toxicologists early in their career seeking more in-depth knowledge and understanding of the role of toxicology in safety assessment. It is also suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) making a career change to work in drug safety assessment.

Applications for CPD credits will again be made to EUROTOX and the Royal Society of Biology.

Register Today: https://execbs.eventsair.com/patdd-2019/patdd2019/Site/Register

Structural Biology 2019 aims to bring together leading academic scientists, researchers, research scholars and entrepreneurs to exchange and share their experiences and research results on all aspects of Structural Molecular Biology and Cell Biology. Structural Biology 2019 delivers a premier interdisciplinary platform for scientists, researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered, and solutions adopted in the fields of Structural and Molecular Biology.

We invite all attendees to contribute throughout the sessions to make the event a memorable from the point of view of learning and Networking.

Structural Biology 2019

The GIS Workshop will be led by Dr. Jeremy R. Porter, one of the highest-rated teachers at the Columbia University Mailman School of Public Health and the author of many celebrated geospatial analysis publications and books.

This two-day intensive course aims to introduce participants to the fundamentals of data visualization using the open-source QGIS program and building towards the introduction of foundational spatially-centered approaches to identifying relationships and associations among population and environmental variables. Led by Dr. Jeremy R. Porter, one of the highest-rated teachers at the Columbia University Mailman School of Public Health and the author of many celebrated geospatial analysis publications and books, this workshop will integrate lectures with hands-on application. The workshop emphasizes the use of open-source software packages and publicly available environmental and demographic data as an example of potential applications of these data with spatially centered visualization and analytic techniques. The workshop is comprised of 4 components 1) visualization, 2) geo-processing, 3) cluster analysis, and 4) relationship identification. Within each component, a lecture is followed by an opportunity to put the methods learned into practice.

There is a limited capacity for the Boot Camp. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate.

Requirements: Each participant must bring a laptop with the software below loaded prior to the first day of the workshop. All of the following packages are available for free download and installation on Mac, PC, and Linux devices: QGIS, saTScan, GeoDa, R, R-Studio

• Paid registration required through RegFox:

The Exposome Boot Camp is led by Dr. Gary Miller and colleagues, a team with extensive experience in exposome analysis from Columbia University, Emory University, and Icahn School of Medicine at Mount Sinai.

This two-day intensive boot camp integrates the principle concepts of exposomics and the untargeted approaches of measuring endogenous and exogenous chemical exposures on an omic scale as we step through the tools and techniques currently available to analyze the exposome. Led by a team of expert scientists in the rapidly growing field of exposomics, the boot camp will integrate seminar lectures with hands-on computer lab sessions to put concepts into practice. Emphasis will be given to leveraging existing resources from ongoing studies and initiating new investigations. The afternoon lab sessions will provide an opportunity to work hands-on with real data. Participants will learn and practice data handling, cleaning, and basic analysis of exposomics data.

There is a limited capacity for the Boot Camp. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate. Basic familiarity with R is recommended to get the most out of the Boot Camp, with tutorials on our website.

• Paid registration required through RegFox:

The Single Cell Analysis Boot Camp is led by Dr. Evan Paull and Dr. Pasquale Laise, a team with extensive experience in single cell analysis from Columbia University’s department of Systems Biology.

This two-day intensive boot camp starts with a fast-paced training session on single cell data collection and basic analysis in the first half-day, then continues with in-depth sessions on advanced methods for phenotyping single cell populations using systems-biology approaches. Led by a team who have invented several of the methods used in network biology and single-cell transcriptome analysis, we demonstrate how to use network models to convert gene expression profiles into protein activity profiles, and how to transfer knowledge between established bulk datasets and novel single-cell data. We expect that, during this hands-on workshop, participants will acquire enough knowledge to plan and perform scRNAseq analyses.

There is a limited capacity for the Boot Camp. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate. Basic familiarity with R is recommended to get the most out of the Boot Camp, with tutorials on our website.

• Paid registration required through RegFox:

The Mendelian Randomization Boot Camp is a two-day intensive combination of seminars and hands-on analytical sessions to provide an overview of the concepts, techniques, packages, data sources, and data analysis methods needed to conduct Mendelian Randomization studies.

This two-day intensive boot camp integrates motivation for Mendelian randomization studies, statistical concepts, genetic considerations, and practical examples to design, implement and interpret a Mendelian randomization analysis. The workshop will integrate seminar lectures with hands-on computer sessions to put concepts into practice. Emphasis will be given to leveraging existing publicly available resources (data, tools and packages) as well as indicating the scope for new studies. The afternoon lab sessions will provide an opportunity to work hands-on with real data. Participants will learn and practice all the steps required for a successful Mendelian randomization analysis using publicly available data, including identifying suitable data sources, data extraction, data alignment, assumption checking and sensitivity analysis.

There is a limited capacity for the Boot Camp. Investigators at all career stages are welcome to attend, and we particularly encourage trainees and early-stage investigators to participate. Basic familiarity with R is recommended to get the most out of the Boot Camp, with tutorials on our website.

• Paid registration required through RegFox:

The Environmental Mixtures Workshop is a two-day intensive training of seminars and hands-on analytical sessions to provide an overview of environmental mixtures concepts, techniques, and data analysis methods used in health studies.

This two-day intensive workshop will provide a rigorous introduction to multiple different techniques to analyze exposure to mixtures in environmental health. The workshop will integrate seminar lectures with hands-on computer lab sessions to put concepts into practice. Emphasis will be given to supervised and unsupervised methods. Since the choice of method depends on the research question at hand, the workshop will conclude with a panel discussion on when each method presented is appropriate for use and for which research questions.

• Paid registration required through RegFox:

Lexis invites all the participants from around the world to attend Pain Medicine 2019 conference to be held in Toronto, Canada on August 30-31, 2019 at 9:00 am.
Our committees have worked to ensure a varied program for Pain Specialists, Anaesthesiologists, Chiropractors, Pharmacists, Acupuncture Doctors, Physiotherapists, Neuropsychologists, Cancer Specialists, Orthopaedicians, Professors/Associate Professors/Assistant Professors/Students in Pain Management, Deans / Vice Presidents of Pain Management Department, Directors / Managers & Business Intelligence Experts of Pharma Industries, Post Doctorals and Researchers in Pain Management, Pharmacology Department. And for any other information regarding the conference, kindly review the descriptions on the website. It includes all the details on the sessions that are planned for these 2 days. The purpose of this meeting is to deliver a comprehensive overview of the latest information, insights and practices in Pain Medicine.

When and Where?
Date: Friday, August 30-31, 2019
Time: 9:00 am – 06:00 pm
Location: Toronto, Canada

Abstract submission deadline is May 1, 2019, with late breaking abstracts due by Aug 29, 2019.

Apply for Travel Awards Today

This year there will be an expanded number of $750.00 travel awards for students, postdocs and new investigators. The application is due on May 1, 2019.

On behalf of the Safety Pharmacology Society (SPS) Board of Directors and Officers, we would like to invite you to attend the 2019 SPS Annual Meeting at the Centre de Convencions Internacional de Barcelona in the beautiful, art-inspired city of Barcelona, Spain.

Over the last few months, the 2019 Program and CE Committees have been hard at work organizing scientific programs and courses that include topics of interest to SPS Members and colleagues. The 2019 Scientific Program features a diverse range of scientific sessions organized into two concurrent themed tracks covering issues such as Cardiac Safety Concerns, New Models: In Vitro, Hot Topics in CNS, Immune Related Adverse Events, Thoughts on Translation, Personalized Medicine, Clinician Perspectives on Safety Pharmacology, Artificial Intelligence/In Silico, Biomarkers – The Far Reaching Value, Early Derisking Strategy and Techniques, Strategies for Getting to FIH and Beyond – Efficiently and Safely, Revisiting S7A and S7B and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest.

The meeting also offers a broad Continuing Education program both on an introductory level as well as advanced courses for the expert. A program outline is now available on the 2019 Meeting website. For those interested in increasing their knowledge, recognition and expertise in the field, we will also be holding the 2019 certification exam for the Diplomate in Safety Pharmacology on September 22 and invite all interested SPS members to consider sitting the exam this year.

In an effort to support attendance from our younger colleagues, please note that there are opportunities for Student and Jr. Investigator Travel and poster awards. We encourage you to submit an abstract for presentation as a poster to be featured in our Exhibit Hall. From these submissions a variety will be selected for short oral communications. The deadline to submit an abstract for presentation is June 15, 2019.

We also would like to highlight our Exhibit Hall, which will feature over 50 vendors offering direct access to CROs, as well as a variety of service and technology providers exhibiting the latest technology and developments relevant to the field.

We cordially invite you to become a member of our Society, become involved in our ongoing scientific activities and join us in Barcelona, Spain for our 2019 Annual Meeting this Fall!

• Natural Diseases of Rodents
• Medical Device Pathology in Rodent Models
• Nanoparticle-related Pathology in Rodent Models
• Toxicology for Pathologists
• Emerging Topics in Clinical Pathology

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

Cell Line Development
PART 1: Early Cell Culture and Cell Line Engineering
PART 2: 3D Cell Culture Models and Applications
Process Development: Upstream Bioprocessing and Analytics
Cell Line Development: Late Stage Cell Line Development, Stability, Data and Assay Data Development
Cell Culture and Downstream Bioprocessing
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

We will have over 600 end users representing internationally renowned research And academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Discussion Workshop and Breakfast: 10x Genomics Platform, Technologies Overview and Updates on The Human Cell Atlas Project.

Healthcare focus: benchmarking RNA Seq sequencing technologies in the clinic, biopsies and single cell analyses to improve stratification of patient and diagnosis.

We will have over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Including 2 interactive streams:

Over two days delegates have the opportunity to debate on burning issues in the industry, learn from top executives and visionaries who are driving the industry, and network with key decision makers for future business opportunities and collaboration.

For sponsorship / exhibition enquiries, please contact Joe Hames via email: joe.hames@ft.com

The 40th Annual Meeting will be at the JW Marriott Desert Ridge in Phoenix, Arizona in 2019.

The Annual Meeting is the heart and soul of the College, a venue for discussing emerging trends in the field of toxicology, networking with friends and colleagues, and professional development. The program is designed by and for members with the goal of providing excellent quality scientific and regulatory content that is directly applicable to the practice of toxicology. The American College of Toxicology is a professional society of a size and culture ideal for scientists of all career stages seeking continuing education, novel and new ideas and strategies, and personal interactions with speakers, other members and guests, and exhibitors.

The 40th Annual Meeting will include a wide-ranging scientific program, a 40th Annual Meeting opening presentation followed by a welcome reception and dinner, the popular traditional poster session reception, awards ceremony and luncheon, distinguished plenary speakers, and networking events. The ACT Annual Meeting offers a unique opportunity for toxicologists preparing for the challenges and decisions that will affect public health and safety in years to come.

The theme of the Conference is “Science and education for action against HPV”. Through workshops, lectures, oral and poster sessions presenting the latest research results, the program will cover papillomavirus (PV)-related topics from basic science to global health impact. We will be paying special attention to HPV prevention and control in populations that are most vulnerable to HPV disease worldwide, including those in Low- and Middle-Income Countries.

Our overarching theme will be harnessing the power of innovation from HPV research to deliver global prevention and control of HPV-related disease.

See you at IPVC 2020!